NCT00082823View on ClinicalTrials.gov

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

May 31, 2008

Conditions
Cancer
Interventions
BIOLOGICAL

ziv-aflibercept

Trial Locations (2)

10021

Memorial Sloan - Kettering Cancer Center, New York

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT00082823 - Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter